Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Accumulated Expenses (2022 - 2025)

Envoy Medical's Accumulated Expenses history spans 4 years, with the latest figure at $250000.0 for Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 5.04% year-over-year to $250000.0; the TTM value through Sep 2025 reached $250000.0, up 5.04%, while the annual FY2024 figure was $570000.0, 83.28% up from the prior year.
  • Accumulated Expenses for Q3 2025 was $250000.0 at Envoy Medical, down from $4.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $6.0 million in Q2 2024 and bottomed at $238000.0 in Q3 2024.
  • The 4-year median for Accumulated Expenses is $3.0 million (2022), against an average of $3.1 million.
  • The largest annual shift saw Accumulated Expenses soared 110.11% in 2023 before it tumbled 94.13% in 2024.
  • A 4-year view of Accumulated Expenses shows it stood at $608000.0 in 2022, then tumbled by 48.85% to $311000.0 in 2023, then soared by 83.28% to $570000.0 in 2024, then tumbled by 56.14% to $250000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Accumulated Expenses are $250000.0 (Q3 2025), $4.7 million (Q2 2025), and $5.1 million (Q1 2025).